Trials / Completed
CompletedNCT03385161
Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic Hyperplasia
Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic Hyperplasia Refractory to Medical Treatment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Male
- Age
- 50 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To compare safely and efficacy of intraprostatic injection of botulinum toxin A versus ethanol for treatment of benign prostatic hyperplasia (BPH).
Detailed description
To compare safely and efficacy of transrectal intraprostatic injection of botulinum toxin A versus ethanol for treatment of symptomatic benign prostatic hyperplasia (BPH) refractory to medical treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Botulinum toxin A | |
| PROCEDURE | Ethanol |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2015-06-01
- Completion
- 2017-06-01
- First posted
- 2017-12-28
- Last updated
- 2017-12-28
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03385161. Inclusion in this directory is not an endorsement.